Gala review
A cash price near thirteen hundred dollars sits beside a lower-dose protocol at a fraction of it.
The verdict
Gala publishes $1,299 a month as a cash price for semaglutide and $149 for a lower-dose tirzepatide protocol on a yearly subscription, read August 2026. Both are stated flat across doses, across fifty states.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- $149/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states
Gala sells both molecules by injection on terms that differ sharply by line. The semaglutide figure is a cash price that insurance may reduce. The tirzepatide figure is a lower-dose protocol.
Who writes the prescription, and what do they see?
A prescription precedes dispensing. The pages describe the two products rather than the clinician. That insurance may apply to one line implies a billing relationship the pages do not otherwise explain.
The gap between the two figures is not a discount and should not be read as one. A cash price of $1,299 and a lower-dose protocol at $149 describe different treatments. Comparing them against each other, or against another seller's single rate, compares things that are not alike.
What happens when the dose goes up?
Both lines are marked flat, so neither figure moves with the dose. The tirzepatide line starts lower by design rather than by discount, so a reader wanting a standard dose should ask what that protocol covers before assuming the $149 applies.
What the price includes
$1,299 a month is a cash figure and the pages state insurance may reduce it, which means the number a reader pays is unknown until a claim is run. $149 on a yearly subscription is $1,788 over twelve months. Neither figure can be set beside a competitor's monthly rate without first establishing what it buys.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Coverage across all fifty states
- Strength: Both lines stated flat across doses
- Strength: Insurance is named as a possible reducer
- Limitation: The cash price is $1,299 a month
- Limitation: The low figure is a lower-dose protocol
- Limitation: The two lines are not comparable
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Gala. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader with insurance that may apply, or one who specifically wants a low-dose protocol.
- Wrong for
- A reader reading the $149 as a standard-dose rate.
How Gala compares
| Seller | Who it suits | Go |
|---|---|---|
| Green Cap Health | Readers in Texas wanting the lowest published figures | See Green Cap Health → |
| Harbor | Readers who value a bundled plan and will ask what raises the floor | See Harbor → |
 Glam Health | Readers who will ask what the plan costs at their own dose | See Glam Health → |
More GLP-1 telehealth sellers reviews: DoctorAdamDrBrainRxDreamHug MedicalDudeMedsEdgeRxEffecty
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Why is semaglutide $1,299?
- It is a cash price, and Gala states insurance may reduce it. What a reader pays is not established until a claim is run.
- Is the $149 tirzepatide a bargain?
- It is a lower-dose protocol on a yearly subscription, which is a different product rather than a discount on a standard one.
- Does either price change with the dose?
- No. Both lines are stated flat across doses.
- Is Gala legit?
- Gala is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Gala expensive compared with other GLP-1 telehealth sellers?
- Gala publishes a starting figure of $149/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Gala below the median, toward the cheaper end. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.